This month, we are focusing on Oncology and have reflected on the notable advancements to oncology medications in recent years....

How CSI supplied large quantities of ruxolitinib to a biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more...